RAC1 and Alzheimer disease: Mechanistically, both statins and NSAIDs inhibit Rho G, Rho-kinase (ROCK), and Rac-1 activity, implying that these pathways may contribute to Aβ accumulation, AD plaques, and dementia, at least in mouse models of AD (Kurata et al. 2011).